165 related articles for article (PubMed ID: 27743172)
1. Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Pituitary; 2017 Apr; 20(2):218-224. PubMed ID: 27743172
[TBL] [Abstract][Full Text] [Related]
2. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.
Olsson DS; Nilsson AG; Bryngelsson IL; Trimpou P; Johannsson G; Andersson E
J Clin Endocrinol Metab; 2015 Jul; 100(7):2651-8. PubMed ID: 25946030
[TBL] [Abstract][Full Text] [Related]
3. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Eur J Endocrinol; 2016 Jul; 175(1):55-61. PubMed ID: 27147638
[TBL] [Abstract][Full Text] [Related]
4. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study.
Esposito D; Ragnarsson O; Granfeldt D; Marlow T; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 May; 178(5):459-469. PubMed ID: 29483205
[TBL] [Abstract][Full Text] [Related]
5. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.
Olsson DS; Hammarstrand C; Bryngelsson IL; Nilsson AG; Andersson E; Johannsson G; Ragnarsson O
Endocr Relat Cancer; 2017 May; 24(5):227-235. PubMed ID: 28274953
[TBL] [Abstract][Full Text] [Related]
6. Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma.
Hammarstrand C; Ragnarsson O; Hallén T; Andersson E; Skoglund T; Nilsson AG; Johannsson G; Olsson DS
Eur J Endocrinol; 2017 Sep; 177(3):251-256. PubMed ID: 28596421
[TBL] [Abstract][Full Text] [Related]
7. Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study.
Oh JS; Kim HJ; Hann HJ; Kang TU; Kim DS; Kang MJ; Lee JY; Shim JJ; Lee MR; Ahn HS
Pituitary; 2021 Feb; 24(1):38-47. PubMed ID: 32949324
[TBL] [Abstract][Full Text] [Related]
8. Hypopituitarism and mortality in pituitary adenoma.
Lindholm J; Nielsen EH; Bjerre P; Christiansen JS; Hagen C; Juul S; Jørgensen J; Kruse A; Laurberg P; Stochholm K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):51-8. PubMed ID: 16817819
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Ubachs DH; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Mar; 100(3):1104-12. PubMed ID: 25574793
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.
Nilsson B; Gustavasson-Kadaka E; Bengtsson BA; Jonsson B
J Clin Endocrinol Metab; 2000 Apr; 85(4):1420-5. PubMed ID: 10770176
[TBL] [Abstract][Full Text] [Related]
11. Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.
Mukai K; Kitamura T; Tamada D; Murata M; Otsuki M; Shimomura I
Endocr J; 2016 Nov; 63(11):965-976. PubMed ID: 27534814
[TBL] [Abstract][Full Text] [Related]
12. Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.
Olsson DS; Trimpou P; Hallén T; Bryngelsson IL; Andersson E; Skoglund T; Bengtsson BÅ; Johannsson G; Nilsson AG
Eur J Endocrinol; 2017 Jan; 176(1):67-75. PubMed ID: 27770012
[TBL] [Abstract][Full Text] [Related]
13. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
14. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.
Olsson DS; Andersson E; Bryngelsson IL; Nilsson AG; Johannsson G
J Clin Endocrinol Metab; 2015 Feb; 100(2):467-74. PubMed ID: 25375987
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
Zueger T; Kirchner P; Herren C; Fischli S; Zwahlen M; Christ E; Stettler C
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1938-42. PubMed ID: 22872686
[TBL] [Abstract][Full Text] [Related]
16. Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up.
Ntali G; Capatina C; Fazal-Sanderson V; Byrne JV; Cudlip S; Grossman AB; Wass JA; Karavitaki N
Eur J Endocrinol; 2016 Feb; 174(2):137-45. PubMed ID: 26546611
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood.
Ragnarsson O; Höybye C; Jönsson PJ; Feldt-Rasmussen U; Johannsson G; Biller BM; Koltowska-Häggström M
Eur J Endocrinol; 2012 Apr; 166(4):593-600. PubMed ID: 22258111
[TBL] [Abstract][Full Text] [Related]
18. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
19. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden.
Ónnestam L; Berinder K; Burman P; Dahlqvist P; Engström BE; Wahlberg J; Nyström HF
J Clin Endocrinol Metab; 2013 Feb; 98(2):626-35. PubMed ID: 23295463
[TBL] [Abstract][Full Text] [Related]
20. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
Tomlinson JW; Holden N; Hills RK; Wheatley K; Clayton RN; Bates AS; Sheppard MC; Stewart PM
Lancet; 2001 Feb; 357(9254):425-31. PubMed ID: 11273062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]